+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide



Comparison of the beta-cytotrophic effect of a new sulfonylurea derivative, glibornuride, and tolbutamide



Klinische Wochenschrift 49(13): 769-770




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042625687

Download citation: RISBibTeXText

PMID: 4935073


Related references

Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea. Arzneimittel-Forschung 22: Suppl 12a:2176, 1972

Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro. Arzneimittel-Forschung 22: Suppl 12a:2179, 1972

Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin. Arzneimittel-Forschung 22: Suppl 12a:2172, 1972

Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin. Arzneimittel-Forschung 22: Suppl 12a:2167, 1972

First experiences with the sulfonylurea derivative glibornuride in diabetes therapy. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 552-554, 1971

Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man. Lancet 1(7502): 1255-1256, 1967

Clinical experiences with the new highly effective sulfonylurea derivative Ro 6-4563 (glibornuride) in long-term therapy of more than 100 aged diabetics. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 554-556, 1971

Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 550-552, 1971

Differences of glibornuride in comparison to tolbutamide regarding induction of microsomal enzymes in man. Diabetologia 10(4): 374, 1974

Mechanism of action of AR 3-ARDF 26, a new betacytotropic sulfonylurea derivative and tolbutamide. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1275-1278, 1972

Effect of intravenous glibornuride and tolbutamide on myocardial contractility. Cardiology 64(4): 208-214, 1979

Effect of Intravenous Glibornuride and Tolbutamide on Myocardial Contractility. Cardiology 64(4): 208-214, 1979

Clinical comparison between glibornuride (Glutril) and tolbutamide in senile diabetes. A controlled doblle-blind trial. Ugeskrift for Laeger 138(26): 1572-1574, 1976

Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial. Current Therapeutic Research, Clinical and Experimental 20(3): 277-282, 1976

Extrapancreatic effects of sulfonylurea compounds. V. Studies on the antilipolytic effect of glibornuride. Arzneimittel-Forschung 22: Suppl 12a:2181, 1972